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Abstract
Propionibacterium acnes is usually a relatively harmless commensal. However, under certain, poorly understood conditions it
is implicated in the etiology of specific inflammatory diseases. In mice, P. acnes exhibits strong immunomodulatory activity
leading to splenomegaly, intrahepatic granuloma formation, hypersensitivity to TLR ligands and endogenous cytokines, and
enhanced resistance to infection. All these activities reach a maximum one week after P. acnes priming and require IFN-c
and TLR9. We report here the existence of a markedly delayed (1–2 weeks), but phenotypically similar TLR9-independent
immunomodulatory response to P. acnes. This alternative immunomodulation is also IFN-c dependent and requires
functional MyD88. From our experiments, a role for MyD88 in the IFN-c-mediated P. acnes effects seems unlikely and the
participation of the known MyD88-dependent receptors, including TLR5, Unc93B-dependent TLRs, IL-1R and IL-18R in the
development of the alternative response has been excluded. However, the crucial role of MyD88 can partly be attributed to
TLR2 and TLR4 involvement. Either of these two TLRs, activated by bacteria and/or endogenously generated ligands, can
fulfill the required function. Our findings hint at an innate immune sensitizing mechanism, which is potentially operative in
both infectious and sterile inflammatory disorders.
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Introduction
The Gram-positive bacterium Propionibacterium acnes (formerly C.
parvum) is a part of the human and mouse flora and an
opportunistic human pathogen. It has been implicated as an
etiologic agent of specific inflammatory diseases, including
sarcoidosis [1–3]. Infection with live or administration of heat-
killed P. acnes in experimental animals and humans leads to a
strong activation of the reticulo-endothelial system. In mice, P.
acnes induces several immunomodulatory activities, including
intra-hepatic granuloma formation, splenomegaly, enhanced
resistance to infection and malignant tumors as well as hypersen-
sitivity to microbial Toll-like receptor (TLR) agonists, such as
lipopolysaccharide (LPS), lipopeptides (LP) or synthetic CpG DNA
analogs [4]. The hypersensitivity is characterized by an overpro-
duction of pro-inflammatory cytokines and an enhanced lethality
in response to TLR triggering. Concomitantly, P. acnes-primed
mice develop hypersensitivity to the endogenous mediators TNF-a
and IL-12 [4–6].
The development of P. acnes effects is dependent on an
extremely slow degradation of internalized bacteria in macro-
phages. This leads to macrophage activation [7,8]. The effects of
P. acnes become detectable 3 days after priming and peak 4 days
later, are dependent on P. acnes recognition via TLR9 in
macrophages [6,9] and require IL-12-mediated IFN-c produc-
tion [5,10,11]. IFN-c, the actual mediator of sensitization, is
produced mainly by CD4
+ T cells and NK cells, however, other
T cell subsets (CD8
+, cdT cells) can also provide this cytokine,
independently of their antigenic specificity. Interestingly, P. acnes
specific T cells are not necessarily required. Thus, T cells play an
important, antigen-independent role in the activation of the
innate immune system by this intracellular microbe. Moreover,
NK cells can substitute for T cells in the production of IFN-c,
however higher amounts of P. acnes have to be used for priming
[6].
Earlier it was shown that only a degradation-resistant P. acnes
strain exhibited immunostimulatory and anti-tumor activities in
mice, while a degradation-sensitive strain was inactive [8]. In
another study, the ability of P. acnes strains to activate the
reticulo-endothelial system was associated with the resistance of
the phagocytosed bacteria to degradation in macrophages [7],
indicating a positive correlation between the immunostimulatory
activity of P. acnes and its relative resistance to degradation.
In agreement, we show here in mice that P. acnes and its
immune effects disappear concomitantly, i.e. between 4 to 6 weeks
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that the absence of TLR9 slows down the bacterial degradation.
Unexpectedly, we found that TLR9-deficient mice also develop
the typical symptoms of hypersensitivity; however, their develop-
ment is strongly delayed. Finally, the underlying mechanisms of
TLR9-independent immune activation by P. acnes are addressed in
this study.
Results
Prolonged Persistence of Bacteria and Delayed
Granuloma Formation in the Liver of P. acnes-primed
TLR9
2/2 mice
We showed previously that the absence of TLR9 impairs the
development of immunomodulatory effects by P. acnes [9]. Here
we investigated, whether the absence of TLR9 influences in any
way the degradation of P. acnes. We injected heat-killed P. acnes, i.v.
into wild-type (wt) and TLR9
2/2 mice and examined the presence
of bacteria in liver, spleen and kidney at different times (up to day
42 after priming) by immunohistochemistry. In wt and TLR9
2/2
animals the bacteria, visualized by the characteristic brown
staining, were present almost exclusively in the liver (Fig. 1), while
spleen and lung remained bacteria-free for the duration of the
experiment (not shown). Four hours after injection, P. acnes was
detectable in the liver associated mainly with sinusoidal lining cells
in both wt and TLR9
2/2 mice.
In wt mice, from day 3 on after priming, intrahepatic
granulomas consisting of mainly mononuclear, partially P. acnes-
positive cells were observed. However, a portion of the P. acnes
remained associated with the sinusoidal lining cells. The number
and size of granulomas reached maximum between days 7 (Fig. 1,
left) and 10 after priming, was moderately reduced after 21 days
(Fig.1, left) and granulomas disappeared after 42 days (Fig 1, left).
The disappearance of granulomas was accompanied by an almost
complete loss of P. acnes detectability.
In TLR9
2/2 mice P. acnes remained associated exclusively with
the liver sinusoidal lining cells and no granuloma formation was
observed in this organ during the first 7 days after administration.
From day 10 on after priming, however, granulomas containing P.
acnes-positive cells appeared in the liver. Their number reached a
maximum on day 21 and these cells were still sporadically present
42 days after P. acnes administration (Fig. 1, right). Our results
show a contribution of TLR9 to the elimination of P. acnes from
the host and reveal the existence of a delayed, TLR9-independent
mechanism of granuloma formation in response to P. acnes
treatment.
Delayed Development of Sensitization and
Splenomegaly in P. acnes-treated TLR9
2/2 mice
The unexpected finding of delayed granuloma formation in
primed TLR9
2/2 mice prompted us to investigate whether other
characteristic immunomodulatory effects of P. acnes also appear
with a similar delay in such animals. For this purpose, we
compared the LPS sensitivity and spleen weights of wt and
TLR9
2/2 mice at different time points (up to day 28) after P.
acnes priming. Plasma levels of TNF-a and IFN-c induced by an
LPS challenge served as a measure of sensitization (Fig. 2A). In
agreement with our earlier studies [9], in wt mice sensitization to
LPS peaked by day 7 after priming, while in TLR9
2/2 mice no
sensitization was observed at this time point. Furthermore, the
cytokine hyper-responses to LPS of primed wt mice decreased
slightly by day 14 and considerably by day 21 and 28 after P.
acnes administration. Enhanced TNF-a and IFN-c responses to
LPS also appeared in P. acnes-primed TLR9
2/2 mice, but with a
marked delay. They were first detectable on day 14 after
treatment, peaked by day 21 and declined again, but were still
slightly enhanced on day 28 after P. acnes administration (Fig. 2A).
Thus, the development of LPS hypersensitivity in P. acnes-primed
mice lacking TLR9 occurs, but it is delayed and of lower
magnitude as in primed wt mice (Fig. 2A). As shown in fig. 2B,
in both wt and TLR9
2/2 mice the development of splenomeg-
aly, another characteristic P. acnes immune effect, correlated
timely with the development of P. acnes-induced LPS hypersen-
sitivity. Thus, while the characteristic enlargement of the spleen
peaked in wt mice on day 7 after priming, we observed in
TLR9
2/2 mice a delayed and less pronounced enlargement of
the organ that reached maximum on day 21.
Delayed Development of Enhanced Resistance to
Typhoid Fever in P. acnes-treated TLR9
2/2 mice
Another hallmark of P. acnes treatment is the development of an
enhanced resistance to infection in the primed animals [12,13]. In
wt mice, peak values of this activity are reached 7 days after
priming. Here we tested whether in the absence of TLR9 signaling
this enhanced resistance to infection develops with a delay, like
sensitization to LPS. For this purpose we infected wt and TLR9
2/
2 mice on day 7 or 21 after priming, as well as the respective
unprimed controls with 200 CFU of Salmonella serovar Typhimur-
ium and determined the number of viable bacteria in the liver
4 days later. As shown in Fig. 2C and in agreement with our
earlier study [9], on day 7 after priming only wt, but not TLR9
2/
2 mice were resistant to Salmonella infection, i.e. exhibited
significantly lower numbers of live bacteria in the liver compared
to the unprimed controls. However, on day 21 after P. acnes
priming we observed significantly enhanced resistance to Salmonella
serovar Typhimurium in TLR9
2/2 mice, while in wt mice the
resistance to infection returned to the pre-priming level. The
above data show that the absence of TLR9 delays the
development of enhanced resistance to infection, mirroring the
development of other immunomodulatory P. acnes effects shown
above.
Requirement for IFN-c and IL-12 in both Early and Late
Immune Activation
Mice lacking functional IFN-c or IL-12 do not develop the
characteristic immune effects up to day 7 after P. acnes treatment
[14–16]. This is confirmed in the present study using IFN-cR
2/2
and IL-12Rb2
2/2 mice (Figure S1 and not shown). We tested
further whether the delayed development of sensitization in P.
acnes-treated mice also requires intact IL-12 and IFN-c signaling.
As shown in Figure S1, both IFN-cR
2/2 and IL-12Rb2
2/2 mice
failed to exhibit LPS hypersensitivity also on day 21 after P. acnes
treatment. Furthermore, splenomegaly and intrahepatic granulo-
ma formation were always absent from these mice (not shown).
Thus, both IL-12 and IFN-c are involved in the immunomodu-
latory response to P. acnes priming.
Complete Absence of P. acnes Effects in MyD88-deficient
mice
The delayed development of the characteristic P. acnes effects in
TLR9
2/2 mice raised the question whether another TLR may
mediate the delayed effects in the absence of TLR9. Since MyD88
is an adaptor essential for signaling through most of the TLRs
[17], we compared the development of P. acnes effects in MyD88
2/
2 mice to that in wt and TLR9
2/2 mice on day 7 and 21 post
priming. We tested for the occurrence of splenomegaly and
intrahepatic granuloma formation, and determined the MyD88-
Innate Immune Activation by P. acnes
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e39155Figure 1. Persistence of P. acnes in livers of WT and TLR9
2/2 mice. Groups of five WT and TLR9
2/2 mice were treated with heat-killed P. acnes
(100 mg/g b.w.) i.v. and livers were removed at different time points after treatment. Immunohisto-chemical staining of liver sections using P. acnes
specific antiserum shows brown P. acnes-specific staining within granulocytes, sinusoidal lining cells and/or granulomas. Left panel: liver of WT mice;
right panel: liver of TLR9
2/2 mice. One representative slide per group of five animals is shown.
doi:10.1371/journal.pone.0039155.g001
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shown in Fig. 3A, wt mice exhibited the expected strong IFN-ab
hyper-responses to LPS challenge on day 7 and weaker, but still
significant, on day 21 after priming, while TLR9
2/2 mice
exhibited only the late LPS hypersensitivity on day 21. On the
contrary, MyD88
2/2 mice did not develop LPS hypersensitivity at
all. Furthermore, unlike the other strains of mouse, primed
MyD88
2/2 animals developed neither splenomegaly (Fig. 3B), nor
the typical intrahepatic granulomas (not shown). Thus, the
absence of MyD88 abolishes both, the early and the late
development of P. acnes effects. The requirement for MyD88
during the early sensitization could be explained easily by the
requirement for TLR9. However, Sun and colleagues reported
that MyD88
2/2 mice exhibit impaired responses to IFN-c [18].
Since IFN-c is a key mediator of the early and late immunomod-
ulatory effects of P. acnes, we first investigated whether a
malfunction of IFN-c might be responsible for the absence of
sensitization in MyD88
2/2 mice.
IFN-c-induced LPS Hypersensitivity in MyD88
2/2 mice
Here, we compared the ability of IFN-c to induce hyper-
reactivity to LPS in vivo [5]. Wt and MyD88
2/2 mice were treated
with recombinant murine IFN-c or vehicle (control) and the
MyD88-independent IFN-ab response to a LPS challenge was
determined. In both types of mouse pretreatment with IFN-c
resulted in a 20-fold enhancement of the IFN-ab response
(Fig. 4A). We further investigated whether MyD88 deficiency
affects the ability of IFN-c to induce IL-12 receptor expression in
macrophages and dendritic cells. The upregulation of IL-12R after
P. acnes-priming on lymphocyte- and NK-cell depleted non-
parenchymal liver cell population is a function of IFN-c [6]. Using
bone marrow derived macrophages (BMMs) and myeloid
dendritic cells (BMDCs) we showed that IFN-c strongly upregu-
lates mRNA levels for IL-12Rb1 and IL-12Rb2 in both cell types,
and that the absence of MyD88 does not impair this function
(Fig. 4B). Thus, it is unlikely that impaired IFN-c function could
explain the absence of the early and late P. acnes effects in
MyD88
2/2 mice.
Normal Development of Delayed P. acnes Effects in mice
with Impaired Intracellular TLR Signaling due to UNC-93B
Deficiency
To explain the requirement for MyD88, we next focused on the
possible importance of intracellular TLRs, distinct from TLR9, in
the late sensitization mechanism. For this purpose we used mice
with a single point mutation in the ER-resident membrane protein
UNC-93B (3d mice), which abolishes signaling via the intracellular
TLRs, including TLR3, 7, 8, 9 and 13 [19–21]. As expected for
animals with impaired TLR9 signaling, we observed no spleno-
megaly, LPS hypersensitivity (Figure S2), or intrahepatic granu-
lomas (not shown) in the 3d mice on day 7 after priming.
However, the UNC-93B deficiency did not abolish the delayed
development of these characteristic P. acnes effects (Figure S2 and
not shown). These results confirm the essential role of TLR9 in the
early immune activation by P. acnes and suggest that intracellular
UNC-93B-dependent TLRs do not have a critical function in the
delayed activation.
Normal Development of Delayed P. acnes Effects in mice
with a Combined TLR2/9
2/2, TLR4/9
2/2 or TLR5/9
2/2
Deficiency
TLR2, 4 and 5 are considered primarily cell surface receptors,
but as shown at least for TLR2 and TLR4 [22–24], they can
also localize and function intracellularly. P. acnes-primed TLR2
2/
2, TLR4
2/2 [25] and TLR5
2/2 (not shown) single deficient
mice, like the respective wt mice, develop the characteristic early
immune effects. To see whether combine defects in TLR2, 4 or 5
may abolish the TLR9-independent late sensitization by P. acnes,
we generated TLR2/9
2/2, TLR4/9
2/2 and TLR5/9
2/2
double deficient mice by crossbreeding. We primed all double
deficient animals with P. acnes and challenged 21 days later with
LPS (TLR2
2/2 and TLR5
2/2 mice) or the TLR2 ligand,
synthetic lipopeptide (LP) FSL-1 (TLR4
2/2 mice). Thereafter,
TNF-a responses were determined. All double deficient mice
exhibited strong late TNF-a hyper-responses (Figure S3) to the
respective TLR ligands and developed splenomegaly and
intrahepatic granulomas with a delay (not shown). Thus, the
additional loss of function of the predominantly surface expressed
TLRs 2, 4 and 5 does not impair the TLR9-independent late
sensitization by P. acnes.
Impairment of IL-1 or/and IL-18 Function Influences
Neither TLR9-dependent nor -independent Immune
Activation by P. acnes
MyD88 is also essential for signaling through the receptors for
IL-1 and IL-18. To address the role of IL-1 and IL-18 in P. acnes-
induced immune activation we generated TLR9
2/2 mice
containing additionally IL-1R or IL-18 deficiencies by backcross-
ing. Wt, IL-1R
2/2, IL-18
2/2, TLR9
2/2, IL-1R/TLR9
2/2 and
IL-18/TLR9
2/2 mice were challenged on day 7 or day 21 after P.
acnes treatment with LPS and their TNF-a and IFN-c responses, as
well as those of the respective unprimed mice were determined. As
shown in Figure S4A, the absence of IL-1 or IL-18 signaling in
TLR9 competent mice impaired neither the early nor the late LPS
sensitization. Furthermore, the absence of either cytokine signaling
in TLR9
2/2 mice did not impair the late sensitization (Figure
S4B). In addition, we used Kineret to block IL-1 function in P.
acnes-primed IL-18/TLR9
2/2 double deficient mice. This con-
comitant loss of IL-1, IL-18 and TLR9 function also failed to
abrogate the development of the delayed LPS sensitization (i.e.
TNF-a or IFN-c hyperresponses) after P. acnes treatment (Figure
S4C).
Figure 2. Delayed development of P. acnes effects in primed TLR9
2/2 mice. Groups of WT and TLR9
2/2 mice (15–20 animals/group) were
primed with heat-killed P. acnes (20 mg/g b.w.) i.v. or remained untreated (controls; day 0). A. Hypersensitivity to LPS: At indicated time points
after priming the animals were challenged with LPS from S.a.e. (0.01 mg/g b.w.), i.v. One hour and 4 h later, plasma was collected for determination of
TNF-a and IFN-c, respectively. Before challenge with LPS no detectable TNF-a or IFN-c was found in plasma of P. acnes-treated mice of either one of
the groups (not shown). Cumulative data of 3 different experiments are shown. *:p-value,0.05 and ***:p-value,0.001 WT compared to TLR9
2/2
mice, and P. acnes-treated WT or P. acnes-treated TLR9
2/2 at the indicated time point compared to untreated controls. B. Splenomegaly: Spleens
were removed and weighted at indicated time points after treatment. Cumulative data from 4–5 experiments are shown. *:p-value,0.05 and **:p-
value,0.01. C. Enhanced resistance to serovar Typhimurium infection is delayed in TLR9
2/2 mice: 7 or 21 days after priming, the animals
were infected with Salmonella serovar Typhimurium (200 CFU/0.2 ml PBS/i.v.). Bacterial counts in liver of unprimed and primed animals were
determined 4 days after infection. One representative experiment of three is shown. *:p-value,0.05 and **:p-value,0.01.
doi:10.1371/journal.pone.0039155.g002
Innate Immune Activation by P. acnes
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in MyD88
2/2 mice after P. acnes treatment. Groups of four to five
WT, TLR9
2/2 and MyD88
2/2 mice were treated with heat-killed P. acnes
(20 mg/g b.w.) i.v. or remained untreated (control). 7 and 21 days after
priming the animals were challenged with LPS S.a.e. (0.01 mg/g b.w.) i.v.
and plasma was collected two hours later for determination of IFN-ab
(A). The spleens were removed and weighted (B). One representative
experiment of many is shown. *:p-value,0.05, **:p-value,0.01 and
***:p-value,0.001.
doi:10.1371/journal.pone.0039155.g003
Figure 4. A.InductionofLPShypersensitivityinmicepretreated
with murine recombinant IFN-c. WT and MyD88
2/2 mice were
treated with recombinant IFN-c (5000 U/0.2 ml) i.v. or remained
untreated (only LPS). Eight hours after pretreatment the animals were
challengedwithLPSS.a.e.(1 mg/gb.w.)i.v.andplasmawascollectedtwo
hourslaterfordeterminationofIFN-ab.Onerepresentativeexperimentof
three,withfourtofivemiceisshown.B.EnhancedexpressionofIL-12Rb1
and IL-12Rb2 in MyD88
2/2 and WT bone marrow derived macrophages
and dendritic cells after stimulation with murine recombinant IFN-c.
1.5610
6 bone marrow derived macrophages (BMM) or dendritic cells
(BMDC)werestimulatedwithmurinerecombinantIFN-c(rIFN-c,3000 U).
After 24 hours, the cells were lysed in guanidinium-thiocyanate solution
and lysates were used for RNA preparation as described in materials and
methods. The mRNA levels were analyzed by quantitative real-time PCR.
Eachvalueisrepresentedasarelativeexpression,whichisevaluatedafter
setting background expression in controls as arbitrary value =1. One
representative experiment of two is shown.
doi:10.1371/journal.pone.0039155.g004
Innate Immune Activation by P. acnes
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Development of P. acnes Immune Effects
A growing number of reports show that TLRs subserve not only
the recognition of microbial ligands (so called pathogen-associated
molecular patterns, or PAMPs), but also of several endogenous
ligands, designated damage-associated molecular patterns
(DAMPs). In some cases, PAMPs and DAMPs may trigger more
than one TLR receptor, as shown for degradation products of
hyaluronic acid (HA) [26,27], a ligand of TLR2 and TLR4. We
showed previously that a double TLR2 and TLR4 deficiency does
not impair the early sensitization to LPS in TLR9 competent mice
[25].Inthatstudy,stronglyenhancedcytokineresponseswerefound
in TLR2/TLR4
2/2 mice challenged 7 days after P. acnes priming
withheat-killedgram-negativebacteria.Totestwhetheracombined
deficiency of TLR2 and 4 has a negative effect on the delayed
development of P. acnes effects we generated TLR2/TLR4/TLR9
tripledeficientmicebycrossbreeding.Wetookadvantageofthefact
thatP.acnes-primedmicebecomehypersensitivetoIL-12,especially
in combination with IL-18 [4], and used the IFN-c response to a
combined administration of the two cytokines as measure of late
sensitization in P. acnes-treated mice. As shown in Fig. 5, the
additional loss of both TLR2 and TLR4, contrary to that of either
one alone (Figure S3), significantly reduced, but did not abolish the
hypersensitivity on day 21 post priming in TLR9
2/2 mice.
Furthermore, it resulted in a significantly less pronounced spleno-
megalyandfewerandsmallergranulomasintheliver(Fig.5).These
datastronglysuggestthatTLR2andTLR4contributetotheP.acnes-
induced TLR9-independent late sensitization and in this function
can substitute for each other.
Discussion
Priming mice with heat-killed P. acnes is a well-established and
widely used mouse model of immunomodulation by intracellular
pathogens. We showed earlier and confirm here that the
immunomodulatory effects of P. acnes, which are fully developed
7 days after priming, require the presence of functional TLR9.
However, our study uncovers an unexpected alternative, TLR9-
independent activation mechanism, developing with a marked
delay of one to two weeks after P. acnes administration. Notably,
the time required for complete elimination of the bacteria in mice
(approximately 4 weeks) is longer in the absence of TLR9. The
relative resistance of P. acnes to in vivo degradation is likely
responsible for immunomodulation. Thus, only P. acnes strains or
preparations which persist in the recipient mice for at least several
days were shown to be stimulatory [8]. The extended duration of
P. acnes persistence in TLR9
2/2 deficient mice suggests an
important role for TLR9 in bacterial degradation. However, the
coincidence between the retarded degradation and the delayed
appearance of immunomodulatory effects in TLR9
2/2 mice
opens the possibility that a certain degree of P. acnes degradation is
necessary to initiate the development of these effects.
Interestingly,thealternativeTLR9-independentactivationmech-
anismleadstothesameimmunephenotypeastheTLR9-dependent
one, i.e. intrahepatic granuloma formation, splenomegaly, hyper-
sensitivitytoTLRligandsandendogenousmediatorsandenhanced
resistance to infection. Since the adaptor MyD88 is essential for
signalingthroughthe majorityofTLRreceptors[17]andTLRsare
importantbacterialsensors,theinvolvementofMyD88intheTLR9-
independent late sensitization was not surprising. However, the
unimpaired late development of the characteristic P. acnes effects in
UNC-93B-deficient mice argues against participation of further
intracellularTLRssuchasTLR3,7,8,11and13[19–21].Moreover,
the additional absence of either TLR2, 4, or 5 individually did not
impair the late immunomodulatory activity of P. acnes in TLR9
2/2
mice.TheroleofTLR1andTLR6inP.acnesactivationhasnotbeen
experimentally excluded. However, so far known, these two TLRs
heterodimerize withTLR2 to constitute functional receptors [28].
The crucial role for MyD88 in the late P. acnes sensitization may
notonlyimplytherequirementforabacterialTLRsensor,butcould
alsosignalizetherequirementfortheIL-1-typecytokines.Microbial
intracellular sensing via specific RIG-I like helicases (RLH) and the
nucleotide binding domain (NBD) and leucine-rich repeat contain-
ing (NLRs) family members leads to proteolytic activation of IL-1b
and IL-18, both signaling through MyD88-recruiting receptors.
Although it is conceivable that peptidoglycan, released during P.
acnes degradation in mice does activate NOD-1, NOD-2 [29], we
excluded here a critical involvement of IL-1b and IL-18 in P. acnes
sensitization by using respective knockout mice and the IL-1R
antagonist Kineret. In accordance, mice deficient for the apoptosis-
associatedspecklikeprotein(ASC),anadaptoressentialforcaspase-
1-mediated IL-1b and IL-18 processing [30], exhibit normal
immune responses to P. acnes priming (unpublished data).
Since IFN-c plays a key role in both, the early [5] and late
immunomodulatory response to P. acnes (this study) and in view of
the importance of MyD88 in IFN-c signaling (as reported by Sun et
al. [18]), an impaired IFN-c function would explain the complete
absence of sensitization in P. acnes-treated MyD88
2/2 mice.
However, this seems unlikely, since upregulation of IL-12R in
macrophages and dendritic cells and induction of LPS hypersensi-
tivityinmice,twoactivitiesofIFNcrelevantforP.acnessensitization
[5,6], remained unimpaired in the absence of MyD88.
Our studyshowsthat deficiencyof asingle ofthe knownMyD88-
dependent TLR receptors does not inhibit the late, TLR9-
independent immunomodulatory response to P. acnes. However,
important physiological functions are often multiple safeguarded.
For example, the TNF-a response, which is essential for infection
control, is triggered by several microbial PAMPs of a sole pathogen
through their specific TLRs. Interestingly in some cases one TLR
ligand activates more than one receptor. This was documented for
degradation products of hyaluronic acid (HA) generated in reaction
to tissue damage [31,32]. These products, depending on molecular
size, activate both TLR2 and TLR4 [26,27]. Importantly,
experiments carried out in mice suggest strongly that endogenous
DAMPs activate both TLR2 and TLR4 and play a decisive role in
the induction of murine allergic contact hypersensitivity [33] and in
protection of lung injury in mice injected with bleomycin [34].
Previously, we excluded a role for TLR2 and TLR4 in the early,
TLR9-dependent P. acnes sensitization to LPS and lipopeptide [25].
However, this studydemonstrates a significantnegative influence of
thecombinedTLR2/4deficiencyonthelatesensitization.Although
TLR2 has been identified as a sensor of P. acnes [35], a similar
property for TLR4 was not seen in our studies (unpublished data),
nor reported elsewhere. Therefore, a possible involvement of
DAMPs induced by the unusually long persistence of bacteria in
host cells may be envisaged, which suggests germ-free mice as a
future experimental model.
At present we cannot determine whether the redundant action of
multiple Myd88-dependent receptors, or an as-yet-unknown
MyD88 function, together with the activity of TLR2 and TLR4
drives the late immunomodulation in P. acnes-primed TLR9
2/2
mice.Onthewhole,ourstudyshowsthattheimmunomodulationby
P. acnes, which is primarily TLR9-dependent, proceeds in the
absenceofTLR9withadelaybyanalternative,MyD88-dependent
mechanism. At least two players involved in this mechanism, TLR2
and TLR4, seem to fulfill a redundant role. Most likely, an IFN-c-
dependent and TLR9-independent mechanism also participate in
immune responses to other microbes and/or DAMPs generated by
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e39155sterile injury, hypothesis which warrant further investigation. Its
elucidationwillcontributetonewstrategiesfordiagnosisandamore
specific treatment of numerous inflammatory diseases.
Materials and Methods
Materials
A highly pure preparation of Salmonella abortus equi LPS in the
uniform triethylamine salt form and heat-killed P. acnes were
prepared as described previously [5,36]. FSL-1 was purchased
from EMC microcollections (Tu ¨bingen, Germany), recombinant
murine IFN-c and IL-12 from NatuTec (Frankfurt a.M.,
Germany), murine IL-18 from MBL laboratories (Nagoya, Japan)
and IL-1 receptor antagonist Kineret (Amgen Europe B.V.) was
kindly provided by S. Martin (University of Freiburg, Germany).
Antiserum to P. acnes was prepared by immunizing rabbits sub-
cutaneously with heat-killed P. acnes, as described earlier [37].
Serum from non-immunized rabbits served as control. The
antiserum and control serum were absorbed with washed murine
splenocytes to remove antibodies directed to mouse tissue.
Animals
Wt (C57BL/10ScSn, C57BL/6, 129Sv/Pas) and all deficient
mice were bred under specific pathogen-free (SPF) conditions inthe
animal facilities of the Max-Planck-Institute of Immunbiology and
Epigenetics. C57BL/10ScN mouse contains a spontaneous entire
deletion of the entire Tlr4 locus [38]. IL-12Rb2-deficient mice
(spontaneous mutation; C57BL/10 background) express a non-
functional IL-12R [39]. Breeding pairs of UNC93B
2/2 [21] and
TRIF
2/2 mice [40] generated by random germ line mutagenesis,
Figure 5. LPS sensitivity of P. acnes primed TLR2/TLR4/TLR9
2/2 mice after. Groups of TLR9
2/2 and TLR2/TLR4/TLR9
2/2 mice were primed
with heat-killed P. acnes (20 mg/g b.w.) i.v. or remained untreated. Each mouse was challenged 21 days after priming with a mixture of murine
recombinant IL-12 (25 ng) and murine recombinant IL-18 (100 ng). Four hours after challenge, plasma was collected for determination of IFN-c.
Before challenge, no detectable IFN-c was found in plasma of P. acnes-treated mice of either one of the groups (not shown). One representative
experiment of two is shown. *:p-value,0.05 and **:p-value,0.01 as compared to only rIL-12+rIL-18-treated controls.
doi:10.1371/journal.pone.0039155.g005
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2/2 [41], IL-1R
2/2 mice [42] and MyD88
2/2 [43]
knockout mice were kindly provided by B. Beutler (The Scripps
Research Institute, La Jolla), H. Wagner (Institute of Medical
Microbiology, Immunology, and Hygiene, Technische Universita ¨t,
Munich, Germany), H. Bluethmann (Transgenic animal models,
Hoffmann-La Roche, Basel), M. Kopf (TH Zu ¨rich) and R.
Landmann (Department Forschung, Kantonspital Basel). All single
deficientknockoutmicewerebackcrossed7–11timestoaC57BL/6
or C57BL/10 background. IFN-c
2/2 mice were bred on a 129Sv/
Ev background [44]. All double deficient mice (TLR2/TLR9
2/2,
TLR4/TLR9
2/2, TLR5/TLR9
2/2, IL-1R/TLR9
2/2 and IL-
18/TLR9
2/2) were generated by crossbreeding respective single
deficient strains and backcrossing the first generation twice to the
TLR9
2/2miceoftherespectivebackground(BL/10orBL/6).The
triple deficient TLR2/TLR4/TLR9
2/2 (BL/10) mice were
obtained after crossbreeding TLR9
2/2 with TLR2/TLR4
2/2
mice and backcrossing the first generation twice to the TLR9
2/2
strain.
For priming, both male and female mice, 7–10 weeks of age
received 20 mg P. acnes/g body weight (b.w.), intravenously (i.v.).
Control mice remained untreated. To inhibit IL-1 function, mice
were treated intraperitoneally (i.p.) with 200 mg Kineret/mouse, 1
day prior to and every other day after P. acnes treatment until 1 day
prior challenge. For cytokines induction P. acnes-treated and
untreated control mice were challenged at the indicated time point
after priming with either LPS (0.01 mg/g b.w.) or FSL-1 (0.5 mg/g
b.w.), or a combination of rIL-12 and rIL-18 (25 ng and 100 ng/
mouse, respectively), i.v. Heparinized blood was collected for
TNF-a, IFN-ab and IFN-c measurements, 1 h, 2 h and 4 h after
challenge, respectively.
All experimental procedures were in accordance with institu-
tional, state and federal guidelines on animal welfare.
Infection
A highly virulent strain of serovar Typhimurium C5 was grown
and the exact numbers of bacteria determined as described
previously [12]. For infection, 200 CFU of bacteria suspended in
0.2 ml of PBS were administered i.v. into the lateral tail vein of
mice. Determination of viable bacteria in the liver was carried out
4 days after infection, as described in [12].
Cell Culture
Bone marrow-derived macrophages (BMMs) were generated
from bone marrow precursor cells in the presence of L-cell-
conditioned medium in hydrophobic Teflon bags as described
previously [45]. After 10 days of culture the cells were washed and
resuspended at a concentration of 5610
5/ml in a serum free, high-
glucose formulation of Dulbecco’s modified Eagle medium
(DMEM) for further use. GM-CSF induced bone marrow-derived
dendritic cells (BMDCs) were generated as described previously
[46]. Mature cells were washed and resuspended at a concentra-
tion of 10
6 cells/ml serum-free RPMI for further use.
Cytokine Determination
TNF-a was measured in a bioassay cytotoxicity test using a
TNF-sensitive L929 cell line of fibroblasts [47] (kindly provided by
L. Old, Memorial Sloan-Kettering Cancer Center, New York,
NY) in the presence of actinomycin D as described previously [5].
The detection limit of the assay was 32 pg TNF-a/ml plasma.
IFN-ab levels were measured using a L929 cell line transfected
with an interferon-sensitive (ISRE) luciferase construct [48]. The
detection limit of the assay was 1 unit/ml. IFN-c was measured
using the OptIEA ELISA kit from BD Biosciences (San Diego,
CA) according to the manufacturer’s instructions. The detection
limit of the assay was 50 pg IFN-c/ml plasma.
Histopathology and Immunoperoxidase Staining
Procedure
Liver, spleen and kidneys of sacrificed mice were fixed in 4%
buffered formaldehyde and paraffin-embedded using routine
protocols. Horizontal organ sections (5 mm thick) were stained
using H&E. To detect P. acnes,5 mm thick horizontal organ
sections were stained with anti-P. acnes or control serum using the
avidin-biotin peroxidase (ABC Method), as described previously
[49]. Cell nuclei were counterstained with hematoxylin (blue).
Stained sections were viewed by light microscopy and pictures
were taken from representative areas of the organ. Brownish color
indicates the presence of P. acnes antigen.
RT-PCR and Real-time RT-PCR
Total RNA was isolated from cells or freshly removed organs
using a guanidinium isothiocyanate-phenol-chloroform-isoamyl
alcohol procedure [50,51] and treated with RNase free DNase I
(Fermentas, St Leon-Rot, Germany) to enhance the purity of the
extracted RNA. The RNA concentration was determined by
absorbance at 260 nm. RNA (1 mg) was reverse transcribed with
Moloney Murine Leukemia Virus reverse transcriptase (M-
MuLV-RT) and oligo-p(dT) primers (Expand reverse transcriptase
kit; Roche, Basel, Switzerland) according to the manufacturer’s
instructions. RT-PCR was performed as described previously [9].
Real-time PCR quantification of RNA expression was performed
using the LightCycler II system (Roche) and the Quantitect SYBR
Green PCR Kit (Qiagen) according to the instructions of the
manufacturers. Arbitrary units of relative expression were
generated by dividing the value obtained for mRNAs under test
by the value of b-actin and multiplying the result by 1000. The
following primer pairs were used: b-Actin: sense, 59-
TGGAATCCTGTGGCATCCATGAAAC; antisense, 59-
TAAAACGCAGCTC AGTAACAGTCCG (348 bp product
size). IL-12Rb1: sense, 59- AGGCCGCCCCTGAGTGCGCC;
antisense, 59- GGCGGTCCCGGCTCCGCAGT (230 bp prod-
uct size) and IL-12Rb2: sense, 59- TTCTTCTTCACTTCCG-
CATA; antisense, 59- CAGATCTCGCAGGTCATATT (210 bp
product size). An annealing temperature of 58uC was used for all
primer pairs. b-actin expression was used to normalize cDNA
levels. The PCR products were analyzed by melting curve and
agarose gel electrophoresis analyses to ascertain the specificity of
the amplification.
Data Analysis and Statistics
Data were analyzed using Prism GraphPad 4.0 software. Data
in figures are presented as mean, error bars show SEM. Statistical
analysis was performed with the unpaired t-test (*:p,0.05;
**:p,0.01; ***:p,0.001).
Supporting Information
Figure S1 LPS sensitivity of P. acnes primed IFN-cR
2/2,
TNF-a
2/2 and IL-12Rb2
2/2 mice. Groups of four to five
mice were treated with heat-killed P. acnes (20 mg/g b.w.) i.v. or
remained untreated (only LPS). 7 and 21 days after priming the
animals were challenged with LPS S.a.e. (0.01 mg/g b.w.) i.v. and
plasma was collected one hour later for determination of TNF-a.
One representative experiment of two is shown. **:p-value,0.01
and ***:p-value,0.001.
(PPT)
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LPS hypersensitivity in 3d mice after P. acnes. Groups of 4
to 5 mice were treated with heat-killed P. acnes (20 mg/g b.w.) i.v.
or remained untreated (only LPS). The animals were challenged
after 7 and 21 days with LPS S.a.e. (0.01 mg/g b.w.) i.v. One hour
and 4 h later, plasma was collected for determination of TNF-a
and IFN-c, respectively. Before challenge with LPS no detectable
TNF-a or IFN-c was found in plasma of P. acnes-treated mice of
either one of the groups (not shown). One representative
experiment of three is shown. *:p-value,0.05, **:p-value,0.01
and ***:p-value,0.001.
(PPT)
Figure S3 LPS sensitivity of P. acnes primed TLR2/
TLR9
2/2, TLR4/TLR9
2/2 and TLR5/TLR9
2/2 mice.
Groups of 5 mice were primed with heat-killed P. acnes (20 mg/g
b.w.) i.v. or remained untreated (only LPS, only FSL-1). After
21 days, unprimed and primed TLR2/TLR9
2/2 and TLR5/
TLR9
2/2 mice were challenged with LPS S.a.e (0.01 mg/g b.w.),
while TLR4/TLR9
2/2 mice were challenged with FSL-1
(0.5 mg/g b.w.). As control, TLR9
2/2 mice were challenged with
either LPS S.a.e or FSL-1. One hour and 4 h after challenge,
plasma was collected for determination of TNF-a and IFN-c,
respectively. Before challenge, no detectable TNF-a or IFN-c was
found in plasma of P. acnes-treated mice of either one of the groups
(not shown). One representative experiment of two is shown. *:p-
value,0.05 and **:p-value,0.01 as compared to only LPS or to
only FSL-1 treated controls.
(PPT)
Figure S4 A. and B. Delayed development of LPS
hypersensitivity in IL-1R
2/2, IL-18
2/2, TLR9/IL-1R
2/2
andTLR9/IL-18
2/2miceafterP.acnespriming.Groupsof
4–5 mice were treated with heat-killed P. acnes (20 mg/g b.w.) i.v. or
remained untreated (only LPS). 7 and/or 21 days later, the animals
were challenged with LPS S.a.e. (0.01 mg/g b.w.) i.v. One hour and
4 h later, plasma was collected for determination of TNF-a and
IFN-c,respectively.BeforechallengewithLPSnodetectableTNF-a
orIFN-cwasfoundinplasmaofP.acnes-treatedmiceofeitheroneof
the groups (not shown). C. LPS sensitivity of TLR9/IL-18
2/2
mice with impaired IL-1 production. Groups of TLR9/IL-
18
2/2 mice were primed with heat-killed P. acnes (20 mg/g b.w.) i.v.
or remained untreated (LPS). One day prior and every other day
afterpriming,theanimalsweretreatedwithkineret(200 mg/mouse)
or vehicle control (PBS) i.p., to antagonize the IL-1 activity. At day
14afterpriming,themicewerechallengedwithLPSS.a.e.(0.01 mg/
g b.w.) i.v. One hour and 4 h later, plasma was collected for
determination of TNF-a and IFN-c, respectively. Spleens were
removed, weighted and spontaneous IL-1b production was
determined from the collected supernatant of lysed splenocytes.
One representative experiment of three is shown. *:p-value,0.05,
**:p-value,0.01 and ***:p-value,0.001.
(PPT)
Acknowledgments
We are indebted to J. Ippisch, P. Lu ¨deritz, H. Garbers, A. Ho ¨lscher and B.
Plessow-Freudenberg for their excellent technical assistance. We are
grateful to J. Lindner for reading the manuscript.
Author Contributions
Conceived and designed the experiments: MAF ST. Performed the
experiments: ST MG CK MAF NF. Analyzed the data: MAF ST CK MG
NF CG. Contributed reagents/materials/analysis tools: CH CJK ML.
Wrote the paper: MAF ST CG NF CJK. English: CG.
References
1 .A b eC ,I w a iK ,M i k a m iR ,H o s o d aY( 1 9 8 4 )F r e q u e n ti s o l a t i o no f
Propionibacterium acnes from sarcoidosis lymph nodes. Zentralbl Bakteriol
Mikrobiol Hyg [A] 256: 541–547.
2. Homma JY, Abe C, Chosa H, Ueda K, Saegusa J, et al. (1978) Bacteriological
investigation on biopsy specimens from patients with sarcoidosis. Jpn J Exp Med
48: 251–255.
3. Ishige I, Usui Y, Takemura T, Eishi Y (1999) Quantitative PCR of
mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients
with sarcoidosis. Lancet 354: 120–123.
4. Freudenberg MA, Tchaptchet S, Keck S, Fejer G, Huber M, et al. (2008)
Lipopolysaccharide sensing an important factor in the innate immune response
to Gram-negative bacterial infections: Benefits and hazards of LPS hypersen-
sitivity. Immunobiology 213: 193–203.
5. Katschinski T, Galanos C, Coumbos A, Freudenberg MA (1992) Gamma
interferon mediates Propionibacterium acnes-induced hypersensitivity to
lipopolysaccharide in mice. Infect Immun 60: 1994–2001.
6. Tchaptchet S, Kirberg J, Freudenberg N, Schamel WW, Galanos C, et al.
Innate, antigen-independent role for T cells in the activation of the immune
system by Propionibacterium acnes. Eur J Immunol 40: 2506–2516.
7. Pringle AT, Cummins CS, Bishop BF, Viers VS (1982) Fate of vaccines of
Propionibacterium acnes after phagocytosis by murine macrophages. Infect
Immun 38: 371–374.
8. Scott MT, Milas L (1977) The distribution and persistence in vivo of
Corynebacterium parvum in relation to its antitumor activity. Cancer Res 37:
1673–1679.
9. Kalis C, Gumenscheimer M, Freudenberg N, Tchaptchet S, Fejer G, et al.
(2005) Requirement for TLR9 in the immunomodulatory activity of Propioni-
bacterium acnes. J Immunol 174: 4295–4300.
10. Heinzel FP, Rerko RM, Ling P, Hakimi J, Schoenhaut DS (1994) Interleukin 12
is produced in vivo during endotoxemia and stimulates synthesis of gamma
interferon. Infect Immun 62: 4244–4249.
11. Merlin T, Gumenscheimer M, Galanos C, Freudenberg MA (2001) TNF-alpha
hyper-responses to Gram-negative and Gram-positive bacteria in Propionibac-
terium acnes primed or Salmonella typhimurium infected mice. J Endotoxin Res
7: 157–163.
12. Gumenscheimer M, Mitov I, Galanos C, Freudenberg MA (2002) Beneficial or
deleterious effects of a preexisting hypersensitivity to bacterial components on
the course and outcome of infection. Infect Immun 70: 5596–5603.
13. Kobayashi F, Nagoya T, Koshi T, Saino Y (1980) Biphasic protection against
bacterial infection in mice induced by vaccination of Propionibacterium acnes.
Infect Immun 27: 391–396.
14. Okamura H, Nagata K, Komatsu T, Tanimoto T, Nukata Y, et al. (1995) A
novel costimulatory factor for gamma interferon induction found in the livers of
mice causes endotoxic shock. Infect Immun 63: 3966–3972.
15. Tanaka Y, Takahashi A, Watanabe K, Takayama K, Yahata T, et al. (1996) A
pivotal role of IL-12 in Th1-dependent mouse liver injury. Int Immunol 8: 569–
576.
16. Tsuji H, Mukaida N, Harada A, Kaneko S, Matsushita E, et al. (1999)
Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacteri-
um acnes-primed IFN-gamma-deficient mice by a concomitant reduction of
TNF-alpha, IL-12, and IL-18 production. J Immunol 162: 1049–1055.
17. Takeda K, Akira S (2005) Toll-like receptors in innate immunity. Int Immunol
17: 1–14.
18. Sun D, Ding A (2006) MyD88-mediated stabilization of interferon-gamma-
induced cytokine and chemokine mRNA. Nat Immunol 7: 375–381.
19. Brinkmann MM, Spooner E, Hoebe K, Beutler B, Ploegh HL, et al. (2007) The
interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is
crucial for TLR signaling. J Cell Biol 177: 265–275.
20. Pifer R, Benson A, Sturge CR, Yarovinsky F (2011) UNC93B1 is essential for
TLR11 activation and IL-12-dependent host resistance to Toxoplasma gondii.
J Biol Chem 286: 3307–3314.
21. Tabeta K, Hoebe K, Janssen EM, Du X, Georgel P, et al. (2006) The Unc93b1
mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like
receptors 3, 7 and 9. Nat Immunol 7: 156–164.
22. Barbalat R, Lau L, Locksley RM, Barton GM (2009) Toll-like receptor 2 on
inflammatory monocytes induces type I interferon in response to viral but not
bacterial ligands. Nat Immunol 10: 1200–1207.
23. Cole LE, Laird MH, Seekatz A, Santiago A, Jiang Z, et al. (2010) Phagosomal
retention of Francisella tularensis results in TIRAP/Mal-independent TLR2
signaling. J Leukoc Biol 87: 275–281.
24. Shibata T, Motoi Y, Tanimura N, Yamakawa N, Akashi-Takamura S, et al.
(2011) Intracellular TLR4/MD-2 in macrophages senses Gram-negative
bacteria and induces a unique set of LPS-dependent genes. Int Immunol 23:
503–510.
25. Lembo A, Kalis C, Kirschning CJ, Mitolo V, Jirillo E, et al. (2003) Differential
contribution of Toll-like receptors 4 and 2 to the cytokine response to Salmonella
Innate Immune Activation by P. acnes
PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e39155enterica serovar Typhimurium and Staphylococcus aureus in mice. Infect
Immun 71: 6058–6062.
26. Jiang D, Liang J, Fan J, Yu S, Chen S, et al. (2005) Regulation of lung injury and
repair by Toll-like receptors and hyaluronan. Nat Med 11: 1173–1179.
27. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, et al. (2002)
Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4.
J Exp Med 195: 99–111.
28. Kawai T, Akira S (2011) Toll-like receptors and their crosstalk with other innate
receptors in infection and immunity. Immunity 34: 637–650.
29. Le Bourhis L, Benko S, Girardin SE (2007) Nod1 and Nod2 in innate immunity
and human inflammatory disorders. Biochem Soc Trans 35: 1479–1484.
30. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, et al. (2004)
Differential activation of the inflammasome by caspase-1 adaptors ASC and
Ipaf. Nature 430: 213–218.
31. Noble PW, McKee CM, Cowman M, Shin HS (1996) Hyaluronan fragments
activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine
macrophages. J Exp Med 183: 2373–2378.
32. Termeer CC, Hennies J, Voith U, Ahrens T, Weiss JM, et al. (2000)
Oligosaccharides of hyaluronan are potent activators of dendritic cells.
J Immunol 165: 1863–1870.
33. Martin SF, Dudda JC, Bachtanian E, Lembo A, Liller S, et al. (2008) Toll-like
receptor and IL-12 signaling control susceptibility to contact hypersensitivity.
J Exp Med 205: 2151–2162.
34. Jiang D, Liang J, Noble PW (2010) Regulation of non-infectious lung injury,
inflammation, and repair by the extracellular matrix glycosaminoglycan
hyaluronan. Anat Rec (Hoboken) 293: 982–985.
35. Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, et al. (2002)
Activation of toll-like receptor 2 in acne triggers inflammatory cytokine
responses. J Immunol 169: 1535–1541.
36. Galanos C, Freudenberg MA, Reutter W (1979) Galactosamine-induced
sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A 76:
5939–5943.
37. Freudenberg MA, Bog-Hansen TC, Back U, Galanos C (1980) Interaction of
lipopolysaccharides with plasma high-density lipoprotein in rats. Infect Immun
28: 373–380.
38. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, et al. (1999) Cutting
edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to
lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol
162: 3749–3752.
39. Wu C, Wang X, Gadina M, O’Shea JJ, Presky DH, et al. (2000) IL-12 receptor
beta 2 (IL-12R beta 2)-deficient mice are defective in IL-12-mediated signaling
despite the presence of high affinity IL-12 binding sites. J Immunol 165: 6221–
6228.
40. Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, et al. (2003) Identification of
Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:
743–748.
41. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. (2000) A Toll-like
receptor recognizes bacterial DNA. Nature 408: 740–745.
42. Haq M, Norman J, Saba SR, Ramirez G, Rabb H (1998) Role of IL-1 in renal
ischemic reperfusion injury. J Am Soc Nephrol 9: 614–619.
43. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, et al. (1998)
Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-
mediated function. Immunity 9: 143–150.
44. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, et al. (1993) Multiple
defects of immune cell function in mice with disrupted interferon-gamma genes.
Science 259: 1739–1742.
45. Freudenberg MA, Keppler D, Galanos C (1986) Requirement for lipopolysac-
charide-responsive macrophages in galactosamine-induced sensitization to
endotoxin. Infect Immun 51: 891–895.
46. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, et al. (1999) An
advanced culture method for generating large quantities of highly pure dendritic
cells from mouse bone marrow. J Immunol Methods 223: 77–92.
47. Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA, et al. (1985) Human
tumor necrosis factor. Production, purification, and characterization. J Biol
Chem 260: 2345–2354.
48. Jiang Z, Georgel P, Du X, Shamel L, Sovath S, et al. (2005) CD14 is required for
MyD88-independent LPS signaling. Nat Immunol 6: 565–570.
49. Lohler J, Gossmann J, Kratzberg T, Lehmann-Grube F (1994) Murine hepatitis
caused by lymphocytic choriomeningitis virus. I. The hepatic lesions. Lab Invest
70: 263–278.
50. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid
guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:
156–159.
51. Sing A, Merlin T, Knopf HP, Nielsen PJ, Loppnow H, et al. (2000) Bacterial
induction of beta interferon in mice is a function of the lipopolysaccharide
component. Infect Immun 68: 1600–1607.
Innate Immune Activation by P. acnes
PLoS ONE | www.plosone.org 11 June 2012 | Volume 7 | Issue 6 | e39155